文献速递胸部肿瘤支持与姑息治疗

免疫系统、抑癌基因与免疫衰老在间皮瘤发生及免疫治疗反应中的相互作用

The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy.
PubMed 文献 · J Thorac Oncol · 2023-11-23

本文聚焦免疫监视在间皮瘤中的作用,探讨衰老过程中抑癌基因功能改变导致的免疫逃逸如何促进基因突变演化与间皮瘤发生。免疫系统、抑癌基因与衰老的相互作用塑造了间皮瘤的免疫景观和异质性肿瘤微环境,并显著影响免疫治疗反应与生存率。

要点

  • 美国间皮瘤死亡病例数每年稳定在约2500例,全球亦呈相似趋势并与人口老龄化相关。
  • 衰老相关的免疫衰老与遗传不稳定性是间皮瘤发生的重要生物学因素,不应被石棉暴露后的长潜伏期所掩盖。
  • 免疫系统、抑癌基因与衰老的相互作用塑造间皮瘤免疫景观及异质性微环境,影响免疫治疗反应与生存率。

核心结论

  • 理解衰老、抑癌基因功能下降与免疫衰老之间的复杂相互作用,可为更有效和个性化的免疫治疗铺平道路,最终为改善间皮瘤治疗结局带来希望。

研究设计与样本

  • 本文为一篇聚焦免疫监视在间皮瘤中作用的专题论述,探讨衰老过程中抑癌基因功能改变所致免疫逃逸对基因突变系统发育与间皮瘤发生的影响。

主要发现

  • 尽管努力禁止石棉开采和制造,美国间皮瘤死亡病例数仍稳定在每年约2500例。
  • 该趋势并非美国独有,而是与全球人口老龄化相关的全球现象。
  • 地缘经济因素如缺乏监管和资源匮乏国家继续制造石棉起一定作用,但衰老相关的免疫衰老和遗传不稳定性等生物学因素也需考虑。
  • 间皮瘤与其他年龄相关癌症共享遗传不稳定性和免疫系统效应,衰老对间皮瘤的影响常在被置于石棉暴露后疾病潜伏期的背景下评估。
  • 常被引为间皮瘤老年 predominance 原因的长潜伏期不应掩盖这些共享机制。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite efforts to ban asbestos mining and manufacturing, mesothelioma deaths in the United States have remained stable at approximately 2500 cases annually. This trend is not unique to the United States but is also a global phenomenon, associated with increased aging of populations worldwide. Although geoeconomic factors such as lack of regulations and continued asbestos manufacturing in resource-poor countries play a role, it is essential to consider biological factors such as immune senescence and increased genetic instability associated with aging. Recognizing that mesothelioma shares genetic instability and immune system effects with other age-related cancers is crucial because the impact of aging on mesothelioma is frequently assessed in the context of disease latency after asbestos exposure. Nevertheless, the long latency period, often cited as a reason for mesothelioma's elderly predominance, should not overshadow the shared mechanisms. This communication focuses on the role of immune surveillance in mesothelioma, particularly exploring the impact of immune escape resulting from altered TSG function during aging, contributing to the phylogenetic development of gene mutations and mesothelioma oncogenesis. The interplay between the immune system, TSGs, and aging not only shapes the immune landscape in mesothelioma but also contributes to the development of heterogeneous tumor microenvironments, significantly influencing responses to immunotherapy approaches and survival rates. By understanding the complex interplay between aging, TSG decline, and immune senescence, health care professionals can pave the way for more effective and personalized immunotherapies, ultimately offering hope for better outcomes in the fight against mesothelioma.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Nel AE, Pavlisko EN, Roggli VL, et al. The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy. J Thorac Oncol. 2023. PMID: 38000500. doi:10.1016/j.jtho.2023.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。